DLX105
/ Novartis, Athenex
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 18, 2019
A Study of DLX105-DMP in Patients With Plaque Psoriasis
(clinicaltrials.gov)
- P1/2; N=20; Not yet recruiting; Sponsor: DelArrivo, Inc.
Clinical • New P1/2 trial
1 to 1
Of
1
Go to page
1